ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0755

Sex Differences in Subtypes of Vascular Involvement and Clinical Manifestations in Giant Cell Arteritis

Natalia Lopez Juanes, Carlota Ureta, Irene Monjo Henry, Maria-Eugenia Miranda-Carus, Chamaida Plasencia-Rodríguez and Eugenio de Miguel, Hospital Universitario La Paz, Madrid, Spain

Meeting: ACR Convergence 2025

Keywords: giant cell arteritis, Imaging, Vasculitis, Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0731–0764) Vasculitis – Non-ANCA-Associated & Related Disorders Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Recognizing gender-specific differences in diseases is critical to improve diagnostic and therapeutic strategies. Giant cell arteritis (GCA) has been traditionally considered a predominantly female disease, but this predominance may be declining with new classification criteria and advanced imaging. While gender-related differences in cranial and extra-cranial GCA phenotypes have been observed, most studies have focused mainly on clinical patterns. The objective of this study is to assess gender-specific differences in GCA clinical presentation, particularly patterns of vascular involvement, age at diagnosis and clinical manifestations.

Methods: This is a retrospective population-based study including consecutive unselected GCA cases from a cohort diagnosed since 2017. Standardized bilateral ultrasound (US) of cranial arteries (common temporal artery and branches) and extra-cranial arteries (carotid, subclavian, axillary) were performed in all patients. Subtypes were categorized as cranial, extracranial, or mixed according to the pattern of vascular involvement identified by ultrasound (US) and/or positron emission tomography-computed tomography (PET-CT). Demographic and clinical data were obtained from medical records, and a confirmed diagnosis required a minimum of six months of clinical follow-up.

Results: A total of 249 GCA cases (table 1) were analyzed (mean age 78.9±8.3 years, range 58–105), with 134 females (53.8%). Cranial involvement was present in 195/249 cases (78.3%), significantly more common in males (84.3%) than females (73.1%, p=0.03). Large vessel involvement was detected in 128/249 patients (51.4%) without significant sex differences (56.5% males vs. 47.0% females, p=0.16)Analysis by subtype showed isolated cranial involvement in 121 patients (48.6%), isolated large vessel vasculitis in 54 (21.7%), and mixed patterns in 74 (29.7%). Significant sex differences were observed: mixed pattern was more frequent in males (40.9% vs. 20.1%, p< 0.01), while isolated large vessel vasculitis was more common in females (26.9% vs. 15.7%, p=0.03). Isolated cranial involvement was also more frequent in females, though not statistically significant.No significant age differences were found between sexes (78.6±8.5 years in females vs. 79.4±8.1 in males) or within vascular subtypes. Clinical manifestations (table 2) were generally more common in women, with significant differences in headache (p< 0.01) and jaw claudication (p=0.04). Women also tended to present more relapses, though this did not reach statistical significance.

Conclusion: GCA shows only a mild female predominance (53.6%). Important sex differences exist in vascular involvement patterns: cranial involvement was more common in males, isolated large vessel vasculitis more frequent in females, and mixed patterns predominated in males (p< 0.01). Age at diagnosis did not differ between sexes. Women tended to present significantly more headache (p< 0.001) and jaw claudication (p=0.04). These findings highlight the need for sex-specific considerations in the diagnosis and management of GCA.

Supporting image 1Table 1: Sex, age and subtypes of GCA.

Supporting image 2Table 2: Clinical manifestations.


Disclosures: N. Lopez Juanes: None; C. Ureta: None; I. Monjo Henry: None; M. Miranda-Carus: None; C. Plasencia-Rodríguez: AbbVie/Abbott, 5, 6, Eli Lilly, 6, Novartis, 6, Pfizer, 5, 6, UCB, 6; E. de Miguel: AbbVie, 1, 5, 6, BMS, 6, Eli Lilly, 1, 6, Grunenthal, 6, Janssen, 1, 6, MSD, 6, Novartis, 1, 5, 6, Pfizer, 1, 5, 6, Roche, 5, 6, Sanofi, 6, UCB, 6.

To cite this abstract in AMA style:

Lopez Juanes N, Ureta C, Monjo Henry I, Miranda-Carus M, Plasencia-Rodríguez C, de Miguel E. Sex Differences in Subtypes of Vascular Involvement and Clinical Manifestations in Giant Cell Arteritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/sex-differences-in-subtypes-of-vascular-involvement-and-clinical-manifestations-in-giant-cell-arteritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sex-differences-in-subtypes-of-vascular-involvement-and-clinical-manifestations-in-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology